test

Master Sciences du médicament et des produits de santé - Parcours : Nanomedecine for drug delivery

Domaine:Sciences, Technologies, Santé

Parcours: Nanomedecine for drug delivery

  • Voir la page en français
  • Crédits ECTS

    120 crédits
  • Niveau d'études visé

    BAC +5
  • Durée

    2 ans
  • Langue(s) des enseignements

    Anglais

Présentation

The EMJMD NANOMED “nanomedicine for drug delivery” (information and applications on our website: http://www.master-nanomed.eu/), directed by Prof. Karine Andrieux and Dr. Caroline Roques, is an English taught curriculum. The first semester is a joint programme with the Master 2 degree « Pharmaceutical Technology » .

 

 

Objectifs

The EMJMD NANOMED aims at educating young scientists towards general principles of drug development. More specifically, this curriculum focuses on drug delivery systems and pharmaceutical technology using both classical dosage forms and innovative delivery systems.

 

Savoir-faire et compétences

Enrolled students are beneficiating from both theoretical and practical courses. Various aspects of pharmaceutical technology related to vectorisation, diagnostic, delivery of innovative drugs (proteins and nucleic acids) but also distinctive features of cosmetic products are part of the curriculum.

 

Niveau d'entréeBac+3

Modalité(s) de formation

  • Formation initiale
  • Formation continue

Validation des Acquis de l'Expérience : Oui

Langue(s) des enseignementsAnglais

StageObligatoire (3 à 6 mois)

Stage à l'étrangerObligatoire (January - June)

Lieu d'enseignement

Programme

Organisation de la formation

Students must validate theoretical and practical courses during semesters 1 and 3 (30 ECTS), theoretical and practical courses and 3-month traineeship during semester 2 (30 ECTS) and a traineeship of 6 months (30 ECTS) during semester 4.

 

First semester: From mid-September to end of January: in Paris University or Patras

Second semester form February to end of March, traineeship from April to June, summer school and workshop in July

Third semester from September to end of December

Semester 4: 6-month traineeship from January to June and final workshop in July

 

Stages

The 3-month-traineeship will be evaluated thanks a poster presentation during the workshop of year 1. A report and a defence of the 6-month traineeship will be presented in the workshop of the second year.

Contrôle des connaissances

Students will be evaluated according to the following European grading system:

Average grade

A

B

C

D

E

Distinction

Excellent

Very Good

Good

Quite Good

Pass

To pass a study unit/course, students must obtain at least an E mark. At the end of each semester, students will have to validate the 30 ECTS according to the modalities defined by the hosting member of the Consortium. The corrected tests will be open to consultation after addressing a formal request to the professor in charge; all kinds of exams (written, oral presentation, individual report etc.) will be stored for one year after the end of the intake at the member of the Consortium in which the exam took place.

In case of failure, a single re-sit examination will be organized; should the student fail again, he/she will have to quit the NANOMED EMJMD.

Following this traineeship, the students will write-up a report that will constitute his/her Master Thesis and that will be submitted to appropriate reviewers. This dissertation will then be presented viva voce during the workshop following the Summer School in front of an International jury.

 

Aménagements particuliers

All information about the 4 European universities partners and our programme are available on the website.

All applications must be done directly on the website : http://www.master-nanomed.eu/.

Admission

Tous les étudiants issus des filières scientifique ou santé

Conditions d'admission

 A bachelor in Pharmaceutical technology, pharmacist, chemist, biologist(biotechnology) or equivalent is mandatory.

Pré-requis

The selection criteria are academic level, English proficiency, previous experience during internship (2 months min) in pharmaceutical technology and a clear professional project. Other mandatory documents are presented in the website: http://www.master-nanomed.eu/.

 

Modalités de candidature

Application form and documents (1st step) directly on the website : http://www.master-nanomed.eu/ and interview in english (2nd step)

 

.

 

Et après ?

Poursuite d'études

This programme is opening up career opportunities in drug delivery and cosmetics but also allowing students to pursue their research training by doing a PhD.

Taux de réussite

95 à 100 %

Le taux de réussite varie de 95 à 100 % selon les promotions

Insertion professionnelle

This programme is opening up career opportunities in drug delivery and cosmetics but also allowing students to pursue their research training by doing a PhD.

 

 

International

Poursuite d'études à l'étranger

PhD opportunities.

 

Mobilité internationale

This programme is a joint European programme : EMJMD Nanomed (information and applications on our website: http://www.master-nanomed.eu/). European and Non-European applicants can beneficiate of grants by applying to this Nanomed master in 2 years.

 

Contact(s)

Composante(s)

Lieu(x) de la formation

  • Site Observatoire
  • Responsable du diplôme
    Karine Andrieux
  • Co-responsable du diplôme
    Caroline Roques

Contact(s) administratif(s)

  • Service de la scolarité

    Faculté de Pharmacie - 4, avenue de l'ObservatoireService de la scolarité75006 ParisTél : 01 53 73 95 40

    Email : scolarite.lmd @ pharmacie.parisdescartes.fr

  • Email address for all information

    Email : nanomed @ pharmacie.parisdescartes.fr

A lire aussi

Formation | Université de Paris
Une nouvelle piste possible pour expliquer les cas graves de la Covid-19

Dans la lutte contre la Covid-19, la compréhension des mécanismes menant à des formes graves de la maladie est un enjeu majeur. Si de nombreuses pistes sont actuellement explorées, des chercheurs d’Université de Paris, de Sorbonne Université, de l’Inserm et du CNRS, ont émis une hypothèse originale, selon laquelle une altération des défenses antioxydantes associée à une proportion anormalement élevée de neutrophiles (globules blancs) expliquerait l’évolution de la maladie vers ses formes les plus graves. Cette hypothèse en cours de validation a fait l’objet d’une publication dans la revue Nature Reviews Immunology le 10 août dernier.

Formation | Université de Paris
Nouveau ! L’espace Carrière des étudiants

Université de Paris se dote d’une nouvelle plateforme d’aide à l’insertion professionnelle, en partenariat avec JobTeaser.

Formation | Université de Paris
Les BU rouvrent leurs portes

Les bibliothèques Grands-Moulins, Sciences, Bichat, Cochin, Cordeliers, Necker,  Villemin, Montrouge, Garancière, BIU Santé – Médecine, BIU Santé – Pharmacie, Jeanne-Chauvin, Henri-Piéron, SHS et STAPS vous accueillent dans le respect des consignes sanitaires en vigueur à Université de Paris.

Formation | Université de Paris
[Mesures sanitaires] Gestes barrières, respectons-les !

Dans le cadre de la lutte contre la pandémie Covid-19, Université de Paris met en place des mesures sanitaires pour que chacun et chacune puisse enseigner, travailler et étudier dans un environnement sûr et protégé.

Logo

Contact

85 boulevard Saint-Germain 75006 Paris
(33) (0)1 57 27 90 00